Human sensory neurons derived from pluripotent stem cells for disease modelling and personalized medicine.
Human sensory neurons derived from pluripotent stem cells for disease modelling and personalized medicine.
复制标题
DOI:
10.1016/j.ynpai.2020.100055
复制
发表时间:
2020-08
期刊:
影响因子:
--
通讯作者:
Zenke M
中科院分区:
文献类型:
--
作者:
Lampert A;Bennett DL;McDermott LA;Neureiter A;Eberhardt E;Winner B;Zenke M
New techniques emerge to study peripheral sensory neurons in iPS-cell derived models. Genetic pain syndromes, e.g. gain- and loss-of-function mutations in Nav-channels are helpful. Individualized treatment for neuropathic pain can be identified with iPS-cell derived nociceptors. In this concise Mini-Review we will summarize ongoing developments of new techniques to study physiology and pathophysiology of the peripheral sensory nervous system in human stem cell derived models. We will focus on recent developments of reprogramming somatic cells into induced pluripotent stem cells, neural differentiation towards neuronal progenitors and human sensory neurons. We will sum up the high potential of this new technique for disease modelling of human neuropathies with a focus on genetic pain syndromes, such as gain- and loss-of-function mutations in voltage-gated sodium channels. The stem cell derived human sensory neurons are used for drug testing and we will summarize their usefulness for individualized treatment identification in patients with neuropathic pain. The review will give an outlook on potential application of this technique as companion diagnostics and for personalized medicine.